CBC Group overview
Stories about CBC Group
The world of drug royalties financing
Asian healthcare specialist CBC Group believes specialised debt funds focused on pharma products can be complementary to equity investments.
Healthcare firm CBC eyes global expansion after closing flagship above hard-cap
CBC, which made its name in Chinese healthcare, will open two international offices this year amid plans to become a 'one-stop' asset management shop, CEO Wei Fu tells PEI.
OpEx Awards 21: Asia-Pacific Small-cap winner – CBC Group
Founded by CBC Group in 2016, Chinese biotech company I-MAB Biopharma has gone on to form significant global licencing agreements.
China’s CBC expands into private credit via healthcare fund – exclusive
Deal sourcing will be led by Peng Fu, a former MD at Chinese investment manager Fosun, according to an investor email seen by PEI.
CBC Group contact information
Offices
88 Market Street #46-04/05, CapitaSpring, Singapore, 048948, SingaporeContacts
| Name | Job title | Location | |
|---|---|---|---|
Key Contact Ms. Vanessa Foong | Job titleDirector, Investor Relations | LocationSingapore, Singapore | Email  --------- |
| Key ContactMs. Leah Gao | Job titleDirector, Fundraising and Investor Relations | LocationShanghai, China | Email -------- |
| Key ContactMr. Gareth Henry | Job titleManaging Director and Global Head of Investor Relations | LocationSingapore, Singapore | Email -------- |
| Key ContactMr. Johan Shah | Job titleDirector, Investor Relations | LocationSingapore, Singapore | Email ---------- |
CBC Group funds managed
Closed funds: 8
| Fund | Fund size | Close date | Strategy |
|---|---|---|---|
Fund size ---------- | Close dateMar 2025 | Strategy --------- | |
Fund size ---------- | Close dateDec 2023 | Strategy ------- | |
Fund size ----------- | Close dateApr 2022 | Strategy -------- | |
Stories that mention CBC Group
What to expect from APAC private equity in 2026
Manager consolidation, HNWI-focused insurance products and a China rebound are on the cards for APAC private equity markets this year.
Chinese healthcare specialist HighLight expands overseas focus
The growth investor will deploy more than 20% of its most recent USD-denominated flagship outside of Mainland China, chief executive Steven Wang told PEI.
Side Letter: Mubadala's PE plans
LP giant Mubadala discloses its preferences for future private equity commitments. Plus: secondaries funds are far more likely to close above target than their PE counterparts; and India's wealth opportunity gathers momentum. Here's today's brief, for our valued subscribers only.
Fundraising headwinds shrink APAC’s footprint in 2024 PEI 300
Several prominent Asia-based firms lost their footing or fell out of the list altogether this year as PE’s distribution drought intensifies.
Side Letter: Partners Group's royalties
Partners Group has launched a new strategy dedicated to private markets royalties. Plus: an exploration of sponsor-led PIPEs; and another Japan fund has reached a close. Here's today's brief, for our valued subscribers only.
What to expect from APAC private equity in 2024
GP stakes, healthcare and Middle Eastern investors will be front of mind for Asia-Pacific markets in 2024.
Side Letter: Northern Trust's PE ETF; Hong Kong's SPAC dreams; new BVCA chair
Northern Trust is giving investors access to private equity, ETF-style. Plus: Duke Street exec named BVCA chair and why being a night owl could be the key to a PE career. Here's today's brief, for our valued subscribers only.
UK pension giant eyes more Asia exposure
The £46bn Border to Coast pension pool wants to benefit from particular growth in China and healthcare in the region.